TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid
TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid
tff pharmaceuticals宣佈與埃默裏大學和生物醫藥先進研究與發展局合作，開發一種乾粉吸入式基於mRNA的治療流感和新冠病毒的藥物
TFF Pharmaceuticals Announced Its New Partnership With Emory University And The Biomedical Advanced Research And Development Authority To Develop A Dry Powder Inhaled Mrna-based Treatment For Influenza And Covid
TFF Pharmicals宣佈與埃默裏大學和生物醫學高級研究與發展局建立新的合作伙伴關係，以開發一種基於乾粉吸入mRNA的流感和Covid治療方法
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間